Re-entry stylet for catheter

Information

  • Patent Grant
  • 10335173
  • Patent Number
    10,335,173
  • Date Filed
    Friday, March 15, 2013
    11 years ago
  • Date Issued
    Tuesday, July 2, 2019
    5 years ago
Abstract
A stylet for re-entry into a vessel includes an elongate body including a proximal portion, a middle curved portion, a pointed distal end, and a longitudinal axis extending through the proximal portion, the middle curved portion, and the pointed distal end. The proximal portion and the middle curved portion have substantially circular cross-sections. The middle curved portion has a pre-shaped curve along the longitudinal axis configured to match a curve of an occlusion-crossing device. The pointed distal end has an s-curve along the longitudinal axis and a flattened portion along the longitudinal axis, the flattened portion having a substantially oblong cross-section.
Description
BACKGROUND

Peripheral artery disease (PAD) affects millions of people in the United States alone. PAD is a dangerous disease that can have catastrophic consequences when left untreated. PAD is the leading cause of amputation in patients over 50 and is responsible for approximately 160,000 amputations in the United States each year.


Peripheral artery disease (PAD) is a progressive narrowing of the blood vessels most often caused by atherosclerosis, the collection of plaque or a fatty substance along the inner lining of the artery wall. Over time, this substance hardens and thickens, which may interfere with blood circulation to the arms, legs, stomach and kidneys. This narrowing forms an occlusion, completely or partially restricting flow through the artery. The most significant of these occlusions are called chronic total occlusions (CTO). Blood circulation to the brain and heart may be reduced by CTOs, increasing the risk for stroke and heart disease.


Interventional treatments for PAD may include endarterectomy and/or atherectomy. Endarterectomy is surgical removal of plaque from the blocked artery to restore or improve blood flow. Endovascular therapies such as atherectomy are typically minimally invasive techniques that open or widen arteries that have become narrowed or blocked. Other treatments may include angioplasty to open the artery. For example, a balloon angioplasty typically involves insertion of a catheter into a leg or arm artery and is positioned such that the balloon resides within the blockage. The balloon, connected to the catheter, is expanded to open the artery. Surgeons may then place a wire mesh tube, called a stent, at the area of blockage to keep the artery open.


Such minimally invasive techniques (e.g., atherectomy, angioplasty, etc.) typically involve the placement of a guidewire through the occlusion. Using the guidewire, one or more interventional devices may be positioned to remove or displace the occlusion. Unfortunately, placement of the guidewire, while critical for effective treatment, may be difficult. In particular, when placing a guidewire across an occlusion, it may be difficult to pass the guidewire through the occlusion while avoiding damage to the artery. For example, it is often difficult to prevent the guidewire from traveling out of the true lumen and into the subintimal layers, such as the adventitia and surrounding tissues. This can cause damage to the vessel and, once out of the true lumen, it can be difficult to direct the guidewire back into the true lumen, thereby preventing effective treatment of the occlusion.


Accordingly, a device for effectively crossing an occlusion and/or for reentering the true lumen after entering the subintimal layers would be beneficial.


SUMMARY OF THE DISCLOSURE

The present invention relates generally to stylets, and more specifically to stylets used to cross occlusions and/or to re-enter a true lumen of a vessel.


In general, in one embodiment, a stylet for re-entry into a vessel includes an elongate body including a proximal portion, a middle curved portion, a pointed distal end, and a longitudinal axis extending through the proximal portion, the middle curved portion, and the pointed distal end. The proximal portion and the middle curved portion have substantially circular cross-sections. The middle curved portion has a pre-shaped curve along the longitudinal axis configured to match a curve of an occlusion-crossing device. The pointed distal end has an s-curve along the longitudinal axis and a flattened portion along the longitudinal axis, the flattened portion having a substantially oblong cross-section.


This and other embodiments can include one or more of the following features. The s-curve can be within the flattened portion. At least one of the distal end or the middle curved portion can include nitinol. The proximal portion can include stainless steel. The pre-shaped curve can form an angle of 130 to 170 degrees. The angle can be approximately 150 degrees. The s-shaped curve can have two curves, the first curve can form a first angle of 120 to 160 degrees and the second curve can form an angle of 120 to 160 degrees. The s-shaped curve can have a first curve and a second curve, the second curve distal to the first curve, and the pre-shaped curve can be aligned in substantially the same direction as the second curve. The pointed distal end can include an anchor. The curved middle portion can be preset to mimic a set bend in an occlusion-crossing catheter.


In general, in one embodiment, a method of re-entering a true lumen during occlusion-crossing includes orienting a distal end of a catheter having a bend therein towards the true lumen of a vessel; introducing a stylet through a guidewire channel of the catheter until a curved middle portion of the stylet aligns with the bend in the catheter and a pointed distal end of the stylet extends out of a distal end of the catheter; advancing the stylet such that the pointed distal end pierces through a wall of the vessel; and directing the catheter over the stylet and into the true lumen of the vessel.


This and other embodiments can include one or more of the following features. The method can further include orienting the stylet within the catheter such that the pointed distal end of the stylet curves sharply towards the vessel wall before advancing the stylet. The method can further include reorienting the catheter within the true lumen after directing the catheter of the stylet. Reorienting the catheter can include reorienting without puncturing an opposite vessel wall. The method can further include determining an orientation of the stylet based upon an alignment of the curved middle portion with the bend in the catheter. The catheter can further include a proximal portion, the proximal portion and the curved middle portions can have substantially circular cross-sections, and the pointed distal end can have a flatted portion and can have a substantially oblong cross-section. The method can further include using image guidance to orient the catheter.


In general, in one embodiment, an assembly for re-entry into a vessel includes a catheter and a stylet. The catheter includes a pre-set curve. The stylet includes an elongate body having a proximal portion, a middle flexible portion, and a distal stiff portion. When the stylet is inserted into the catheter, the flexible portion is configured to conform to the pre-set curve and the distal stiff portion is configured to at least partially straighten the pre-set curve. The flexible portion has a length such that the flexible portion can align with the pre-set curve both while the distal stiff portion remains inside the catheter and while the distal stiff portion extends distally from a distal end of the catheter.


This and other embodiments can include one or more of the following features. The distal stiff portion can include a sharp pointed end. The middle flexible portion can include a flexible coil. The proximal portion can be stiffer than the middle flexible portion.


In general, in one embodiment, an assembly for re-entry stylet for re-entry into a vessel includes a catheter and a stylet. The catheter includes a pre-set curve. The stylet includes a flexible elongate body having a pointed distal end. The stylet further includes a stiff tube concentric with the flexible elongate body, the flexible elongate body axially movable relative to the stiff tube. When the stylet is inserted into the catheter, the flexible portion is configured to conform to the pre-set curve, and the flexible elongate body is configured to at least partially straighten the pre-set curve.


This and other embodiments can include one or more of the following features. The flexible elongate body can include a pre-set curve configured to match the pre-set curve of the catheter. The flexible elongate body can include a shape memory material.


In general, in one embodiment, a stylet for re-entry into a vessel includes an elongate body having a pointed distal tip. The stylet includes a coiled member attached to the pointed distal tip. The coiled member includes a relaxed configuration where the coiled member extends over the pointed distal portion and a compressed configuration wherein the coiled member is compressed to expose at least a portion of the pointed distal tip.


Methods of using the stylets to reenter a lumen, such as for occlusion crossing, are also described herein.





BRIEF DESCRIPTION OF THE DRAWINGS

The novel features of the invention are set forth with particularity in the claims that follow. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:



FIG. 1A is a side view of the distal end of an exemplary directional re-entry stylet.



FIG. 1B is a close-up of the distal tip of the directional re-entry stylet of FIG. 1B.



FIG. 2A is a schematic of a directional re-entry stylet such as the one shown in FIG. 1A.



FIG. 2B is a close-up of the distal tip shown in FIG. 2A.



FIG. 2C is a close-up of the junction shown in FIG. 2A.



FIG. 3A is a schematic of an exemplary aligning re-entry stylet having a central flexible section.



FIG. 3B is a close-up of the flexible section of the aligning re-entry stylet of FIG. 3A.



FIGS. 4A-4C show the re-entry stylet of FIG. 3A in an exemplary CTO crossing device with a pre-set curve. FIG. 4A shows the re-entry stylet is aligned within the device such that the angle of the pre-set curve is not changed by the stylet. FIG. 4B shows the exemplary CTO crossing device straightened using the re-entry stylet. FIG. 4C shows the exemplary CTO crossing device with the re-entry stylet extending from the distal end.



FIGS. 5A-5C show an exemplary process for producing the stylet of FIG. 3A.



FIG. 6 shows an exemplary bilayer re-entry stylet having a stiff outer tube and a flexible inner elongate body.



FIGS. 7A-7D shows the bilayer re-entry stylet of FIG. 6 in an exemplary CTO crossing device with a pre-set curve. FIG. 7A shows the stylet placed such that both the outer tube and the inner elongate body are proximal of the pre-set curve. FIG. 7B shows the outer tube moved distal to the pre-set curve such that the pre-set curve is straightened. FIG. 7C shows the outer tube positioned proximal to the pre-set curve and the inner elongate body extended out the distal end of the catheter. FIG. 7D shows the outer tube moved distal to the pre-set curve such that the pre-set curve is straightened and the inner elongate body extended out the distal end of the catheter.



FIG. 8 shows an exemplary manipulator for steering a re-entry stylet.



FIG. 9A shows an exemplary stylet tip having a hook anchoring mechanism. FIG. 9B shows an exemplary stylet tip having a drill anchoring mechanism.



FIG. 10A shows a spring-loaded stylet in passive mode. FIG. 10B shows a spring-loaded stylet in active mode.



FIG. 11A shows an exemplary occluded vessel. FIG. 11B shows an occlusion-crossing catheter that has extended into the subintimal layers of the occluded vessel of FIG. 11A. FIG. 11C shows the occlusion crossing catheter of FIG. 11B trapped in the subintimal layer.



FIGS. 12A-12D show use of a stylet similar to the stylet of FIG. 1A to guide a catheter from the subintimal layer back into the true lumen. FIG. 12A shows the stylet pointing out of the catheter. FIG. 12B shows the stylet piercing through the vessel wall. FIG. 12C shows the catheter reentering the true lumen over the stylet. FIG. 12D shows the catheter reoriented within the true lumen.



FIGS. 13A-13C show use of a stylet similar to the stylet of FIG. 4A to guide a catheter from the subintimal layer back into the true lumen. FIG. 13A shows the stylet piercing the vessel wall. FIG. 13B shows the catheter reentering the true lumen over the stylet. FIG. 13C shows the catheter reoriented within the true lumen.



FIGS. 14A-14D shows use of a stylet similar to the stylet of FIG. 6 to guide a catheter from the subintimal layer back into the true lumen. FIG. 14A shows the stylet within the catheter. FIG. 14B shows the stylet piercing the wall. FIG. 14C shows the catheter reentering the true lumen over the stylet. FIG. 14D shows the stylet straightening the catheter to reorient it within the true lumen.





DETAILED DESCRIPTION

Referring to FIG. 11A, an occluded vessel 1000 includes a lumen 1022 (or “true lumen”) with an occlusion 1021 and an arterial wall 1020. The arterial wall 1020 can include an innermost intimal layer 1026, which can include the endothelium, the subendothelial layer, and the internal elastic lamina. A relatively soft medial layer 1028 (also called the “subintimal space”) surrounds the intimal layer 1026, which is then surrounded by an advential layer 1024. The proximal and distal caps 1042, 1044 of the occlusion are generally very hard relative to the rest of the occlusion. As a result, when a guidewire or occlusion-crossing device hits one of the caps 1042, 1044, it can often end up deflecting off of the cap 1042, 1044 and extending through the intimal layer 1026 and into the relatively soft medial layer 1028. For example, referring to FIG. 11B, an occlusion-crossing device 1100 has extended into the subintimal space within the medial layer 1028, which can define a “false lumen.” As shown in FIG. 11C, the occlusion-crossing device 1100 can then get trapped in the subintimal space outside the true lumen 1022.


Stylets are described herein that can be used to assist in occlusion-crossing within a blocked vessel. For example, in some embodiments, the stylets described herein can redirect occlusion-crossing devices back into the true lumen of a vessel. In addition or alternatively, the stylets described herein can straighten and/or deflect an occlusion-crossing device to orient the device as needed.


In general, any of the stylets described herein can have a deflection region at the distal end thereof to provide directionality and steerability of the catheter. The deflection region can, for example, be imparted by a pre-shaped curve that matches an inner lumen of a catheter. The deflection region can also be imparted by an s-shaped curve at the distal tip of the stylet that helps orient and direct the stylet back into the true lumen of a vessel. In some embodiments, the deflection region can have a flattened profile to provide stability during piercing of the vessel wall into the true lumen.


Any of the stylets described herein can further be designed to include both flexible and stiff portions along the longitudinal axis to aid both in conforming the stylet to a catheter in which it is inserted and in providing the necessary stiffness to puncture a vessel wall. The stylets can include a proximal portion, a middle flexible portion, and a distal stiff portion. The middle flexible portion can be flexible enough to conform to a curve of a catheter in which the stylet is inserted while the distal stiff section can be stiff enough to provide a piercing force to guide the stylet into a true lumen of a vessel.


The stylets described herein can include an inner flexible body and an outer stiff tube. The flexible body and outer stiff tube can be moved axially relative to one another to provide the desired stiffness or flexibility for the stylet, e.g., to provide flexibility to extend around a pre-set curve in a catheter or to provide stiffness to straighten the pre-set curve. In other embodiments, the inner body can be stiff while the outer tube can be flexible.


Furthermore, the stylets described herein can include a coiled member attached to the distal tip to provide protection for the tip when in the extended configuration and allow for exposure of the tip when compressed.


Referring to FIGS. 1A through 2C, an exemplary directional re-entry stylet 100 includes a proximal portion 101, a middle curved portion 102, and a distal pointed end 103.


The proximal portion 101 can be a wire, such as a stainless steel wire. The wire can be chosen to have a stiffness that corresponds to the required amount of pushability and column support needed for the particular wire diameter used. The proximal portion 101 can further have a substantially round cross-section. The proximal portion 101 can be approximately 0.010 to 0.035 inches in diameter, such as approximately 0.015 inches in diameter.


The curved middle portion 102 can have a pre-set curve 105 that is flexible enough to follow the contours of lumen of a catheter but stiff enough to orient its curved shape to align with a bent section of an the catheter. For example, referring to FIG. 2B, the pre-set curve 105 can form an angle α of between 120 degrees and 180 degrees, such as between about 130 degrees and 170 degrees, for example approximately 150 degrees. The pre-set curve can advantageously ensure that the stylet 100 aligns properly with the catheter in which it is inserted, thereby allowing the catheter to maintain its curved form and ensuring proper steering of the catheter.


Further, in other embodiments, the pre-set curve 105 can be stiff enough to change the deflection region of the catheter in which it is inserted. Thus, for example, the pre-set curve 105 could force the catheter into a set angle of between 120 degrees and 180 degrees, such as between about 130 degrees and 170 degrees, such as 150 degrees. In some embodiments, rather than having a pre-set curve, the curved middle portion 102 can have a flexible portion, such as a necked section or a coiled section, to allow the middle portion 102 to flexibly conform to the shape of a catheter in which it is inserted.


The curved middle portion 102 can be formed of a wire, such as a nitinol wire. The curved middle portion can further have a substantially round cross-section. The curved middle portion 102 can have a diameter of approximately 0.008 inches to 0.015 inches, such as approximately 0.012 inches in diameter. In some embodiments, the middle portion 102 is formed separately from the proximal portion 101 and connected through a junction 106, such as a hypotube joint (see FIG. 2C) or a laser welded sleeve. In other embodiments, the middle portion 102 and proximal portion 101 can be formed of a single piece of material, such as a single wire.


The pointed distal end 103 can include an s-shaped curve 107 (see FIGS. 1B and 2B), i.e., include two opposing curves 109 and 111 along the longitudinal axis. Referring to FIG. 2B, the proximal-most curve 109 of the s-shaped curve 107 can have an angle β of between approximately 90° to 180°, such as between about 120° to 160°, such as 150°, while the distal-most curve 111 of the s-shaped curved 107 can have an angle θ of between approximately 90° to 180°, such as 120° to 160°, such as 150°. The s-curve 107 can be oriented such that the distal end 103 points in approximately the same direction as the end of the catheter, as set by the pre-set curve 105. That is, referring to FIG. 2B, the angle α can be oriented in approximately the same direction as the angle θ while the angle β can be aligned in substantially the opposite direction. Angles β and θ can be approximately equal to one another. Further, having the distal end 103 point in the same direction as the distal end of the catheter (set by the jog in the catheter) advantageously provides more of an angle for re-entry into a true lumen. Finally, the alignment of the angle α with the angle θ also advantageously provides an indication as to the orientation of the stylet.


The distal tip 115 (between the distal-most point and the distal curve 111) can be less than about 3 mm, such as between about 1-2 mm. Further, the stylet 100 itself can be about 150 cm-300 cm in length, such as 175 cm to 200 cm, such as approximately 180 cm in length. Thus, the distal tip 115 can comprises less than 1%, such as less than 0.5% of the total length of the stylet 100. The short length of the distal tip 115 relative to the length of the entire stylet 100 advantageously provides that the stylet will advance only partially through the vessel wall and back into the true lumen during reentry (i.e., to avoid puncturing the opposite wall of the vessel).


In other embodiments, rather than having an s-shaped curve 107, the pointed distal end 103 can include a J-shaped curve, i.e. a hook, that can be used to force the stylet 100 (and thus the catheter in which it is inserted) back towards a true lumen.


The pointed distal end 103 can further included a flattened portion, i.e., a portion in which the otherwise round cross-section has been flattened to include two substantially parallel and flat surfaces, e.g., such that a cross-section of the flattened portion is substantially oblong. As shown in FIG. 1B, the s-curve 107 can be located within the flattened portion such that the shape of the “s” is formed on the flattened surface. This flattened portion can advantageously help to hold the pre-set curve as it is forced against tissue. The flattened portion can also advantageously provide rigidity as the tip of the stylet is forced into tissue.


Further, the pointed distal end 103 can be tapered from the proximal end to the distal end. For example, the distal end can be 0.012 inches in diameter and can taper down to a tip 115 of approximately 0.005 inches in diameter. The tip 115 of the pointed distal end 103 can be sharp, i.e., can be configured to penetrate tissue, such as subintimal layers of a blood vessel. The taper can advantageously provide smooth dilation or entry into a vessel wall or occlusion.


Referring to FIGS. 12A-12D, in one embodiment, a stylet 100 can be used as a re-entry tool for an occlusion-crossing catheter 1100 that has exited the true lumen 1022 and entered the subintimal layer (e.g., medial layer 1028). The stylet 100 can be placed through a guidewire channel of a catheter 1100. The catheter 1100 can have a fixed bend 1114, which can be rotated to point towards the true lumen 1022. As shown in FIG. 12A, the stylet 100 can be threaded through the catheter 1100 such that the curved middle portion 102 aligns with the bend 1114 in the catheter 1100 and such that the tip 115 points out the distal end of the catheter. Because the angle of the curved middle portion 102 is pointed in the same direction as the distal-most curve of the s-shaped curve, and because the fixed bend 1114 has been oriented towards the true lumen 1022, the distal tip 115 will also point towards the true lumen 1022. Further, referring to FIG. 12B, because the curved middle portion 102 has a pre-set curve, the curve will hold the stylet's orientation as it is advanced. Thus, as the stylet is advanced, the distal tip 115 will curve even more sharply towards the true lumen 1022 and pierce back through the tissue of the vessel wall 1020 at a steep angle (e.g. at an angle of between approximately 60 and 90 degrees relative to the wall). Referring to FIG. 12C, the catheter 1100 can then be advanced over the stylet 100 back into the true lumen 1022. As shown in FIG. 12D, to reorient the catheter 1100 towards down the axis of the lumen 1022, the catheter can be rotated approximately 180 degrees to point the fixed bend 1114 down the lumen 1022. In some embodiments, this process can be used to pass entirely by an occlusion (as shown in FIGS. 12A-12D). In other embodiments, the stylet 100 can direct the catheter 1100 back into the occlusion at a point between the proximal 1042 and distal 1044 caps of the occlusion 1021, and then the catheter 1100 can be used to finish crossing through the lesion, such as will a rotating drill feature on the distal end of the catheter.


Referring to FIGS. 3A-3B, an aligning re-entry stylet 200 includes a proximal portion 201, a middle flexible portion 202, and a distal stiff portion 203.


The proximal portion 201 can be a wire, such as a stainless steel wire. The wire can be stiff enough to provide pushability through a catheter. The proximal portion 201 can be approximately 0.010 to 0.038 inches in diameter, such as approximately 0.015 inches in diameter.


The middle flexible portion 202 is configured to be flexible so as to conform to the shape of a catheter in which it is inserted. In one embodiment, the flexible portion 202 is a coil, such as a coil of wire. The coil can have an outer diameter of 0.010 to 0.038 inches, such as approximately 0.014 inches and an inner diameter of 0.005 to 0.010 inches, such as approximately 0.008 inches. The coil can be made, for example, of stainless steel. The wire forming the coil can have a diameter of 0.001 to 0.005 inches, such as approximately 0.003 inches. In another embodiment, the middle flexible portion 202 could be a necked portion in a wire. In another embodiment, the middle flexible portion 202 can be a separate flexible material, such as a plastic. In another embodiment, the middle flexible portion 202 can be a hypotube that has been cut, such as laser cut, into a flexible spiral or plurality of rings along a spine.


The proximal stiff portion 203 can be stiff enough to straighten a prebent catheter in which it is inserted. For example, the proximal stiff portion can be made of a stainless steel wire. The wire can have a diameter, for example, of 0.010 to 0.038 inches, such as approximately 0.015 inches. The distal portion 203 can further include a sharp tip 212, such as a needle-like or pointed end. In some embodiments, the sharp tip 212 can be angled to assist in re-entry.


The flexible portion 202 can have a length such that the flexible portion can align with a pre-set curve 414 in a catheter 400 in which it is inserted both while the distal stiff portion 203 remains inside the catheter 400 (FIG. 4A) and while the distal stiff portion 203 extends distally from the distal end of the catheter 400 (FIG. 4C).


In use, referring to FIGS. 4A-4C, the stylet 200 can be inserted into a catheter, such as a catheter 400 having a pre-bent curve 414. As shown in FIG. 4A, the stylet 200 can be inserted such that the flexible portion 202 aligns with the pre-bent curve 414 while the distal portion 203 remains inside the catheter. This alignment can advantageously provide little interference with the catheter as the catheter is used under normal conditions.


The stylet 200 can also be inserted such that the distal stiff portion 203 aligns with the pre-bent curve 414, thereby straightening the curve, as shown in FIG. 4B. This alignment can advantageously make directly entry into an occlusion easier, i.e., placing force on a straightened catheter, from within the true lumen, can provide a straight trajectory into the occlusion.


Finally, as shown in FIG. 4C, the stylet 200 can be inserted such that the flexible portion 202 aligns with the pre-bent curve 414 while the distal portion 203 extends out of the distal end of the catheter 400. This alignment can advantageously assist in re-entry from a false lumen to a true lumen, i.e., the curve of the catheter 400 can be turned towards the true lumen, and the distal end 203 of the stylet 200 can be used to pierce the vessel and guide the catheter 400 back into the true lumen. For example, FIGS. 13A-13C show a stylet 200 used as a re-entry tool for an occlusion-crossing catheter 1100 that has exited the true lumen 1022 and entered the subintimal layer (e.g., medial layer 1028). The stylet 200 can be placed through a guidewire channel of the catheter 1100. The catheter 1100 can have a fixed bend 1114, which can be rotated to point towards the true lumen 1022. As shown in FIG. 13A, the stylet 200 can be threaded through the catheter 1100 such that the flexible portion 202 aligns with the fixed bend 1114 while the distal portion extends out of the distal end of the catheter 1100. Because the fixed bend 1114 has been oriented towards true lumen 1022, the sharp distal portion 203 will also point towards the true lumen 1022, making it easy to pierce the wall 1020. Referring to FIG. 13B, the catheter 1100 can then be advanced over the stylet 200 back into the true lumen 1022. As shown in FIG. 12C, to reorient the catheter 1100 towards down the axis of the lumen 1022, the catheter can be rotated approximately 180 degrees to point the fixed bend 1114 down the lumen 1022. In some embodiments, this process can be used to pass entirely by an occlusion (as shown in FIGS. 13A-13C). In other embodiments, the stylet 200 can direct the catheter 1100 back into the occlusion at a point between the proximal 1042 and distal 1044 caps, and then the catheter 1100 can be used to finish crossing through the lesion, such as with drilling features on the catheter 1100.


Referring to FIGS. 5A-5C, a stylet 200 can be made, for example, by grinding two mandrels to a taper 510a,b (the mandrels will form the proximal and distal ends, respectively), and then placing the tapers 510a,b inside a coil 202 and connecting the coil 202 to each taper 510a,b, as shown in FIG. 5C.


Referring to FIG. 6, a stylet 300 can include an outer tube 310 and an inner elongate body 312 axially movable relative to the outer tube 310. The outer tube 310 can be stiff relative to the inner elongate body 312. The inner elongate body 312 can have a pointed or sharp distal end 303 similar to the distal end of the stylets 100, 200. The inner elongate body 312 and/or the outer tube 310 can be made of a metal, such as stainless steel or nitinol.


Further, referring to FIGS. 7A-7B, the stylet 300 can be configured to be placed within a lumen of a catheter, such as a catheter 500 having a pre-set curve 514. The outer tube 310 can be stiff relative to the pre-set curve 514 while the inner elongate body 312 can be flexible relative to the pre-set curve 514. As a result, the outer tube 310 can be used to straighten the pre-set curve 514 while the inner elongate body 312 can conform to the pre-set curve 514.


Thus, referring to FIG. 7A, the stylet 300 can be placed such that the entire stylet 300 is proximal to the pre-set curve 514. As shown in FIG. 7B, if the outer tube 310 is advanced distal to the pre-set curve 514, then the pre-set curve 514 of the catheter 500 will substantially straighten out. Such straightening can be advantageous, for example, if the catheter 500 is being used to cross a CTO from within the true lumen, as force can be applied on the CTO from substantially perpendicular to the CTO. Referring to FIG. 7D, the inner elongate body 312 can also be extended out of the distal end of the catheter while the catheter is in a straightened position to assist with crossing the CTO (e.g. such that the pointed distal end 303 can cut through the occlusion or pierce the proximal or distal cap). On the other hand, as shown in FIG. 7C, if only the inner elongate body 312 is advanced distal to the pre-set curve 514, then the pre-set curve 514 can maintain its shape while the pointed distal end 303 can be advanced out of the catheter 500. This configuration can be advantageous, for example, for re-entry form a false lumen to a true lumen, i.e. the curve 514 of the catheter 514 can be turned towards the true lumen, and the pointed distal end 303 of the inner elongate body 312 can be used to pierce the vessel and guide the catheter 500 back into the true lumen.



FIGS. 14A-14D show a stylet 300 used as a re-entry tool for an occlusion-crossing catheter 1100 that has exited the true lumen 1022 and entered the subintimal layer (e.g., medial layer 1028). As shown in FIG. 14A, the stylet 300 can be placed through a guidewire channel of the catheter 1100. The catheter 1100 can have a fixed bend 1114, which can be rotated to point towards the true lumen 1022. Referring to FIG. 14B, the inner elongate body 312 can then be extended towards the true lumen 1022. Because the fixed bend 1114 has been oriented towards the true lumen 1022, the pointed distal end 303 will also point towards the true lumen 1022, thereby allowing it to pierce the vessel wall 1020 as it is extended. Referring to FIG. 14C, the catheter 1100 can then be advanced over the stylet 300 back into the true lumen 1022. As shown in FIG. 12D, the outer tube 310 can then be extended within the catheter 1100 such that it straightens the fixed bend 1114. Such straightening of the fixed bend 1114 will point the catheter 1100 more directly down the true lumen 1022. In some embodiments, this process can be used to pass entirely by an occlusion (as shown in FIGS. 14A-14D). In other embodiments, the stylet 300 can direct the catheter 1100 back into the occlusion at a point between the proximal 1012 and distal 1044 caps, and then the catheter 1100 can be used to finish crossing through the lesion.


In some embodiments, the inner elongate body 312 can have a pre-set curve that substantially matches the pre-set curve 514 of the catheter 500. For example, the inner elongate body 312 can be made of a shape memory material, such as nitinol, to set the curve. Having this matched curve can advantageously help with re-entry into the true lumen. That is, if the user steers the directionality of the catheter 500 towards the true lumen, then when the curved inner elongate body 312 exits, it will curve and be directed towards the true lumen even more than the catheter itself, helping to avoid deflection off of the vessel wall.


In general, a sharp distal tip of any of the stylets described herein may be protected or covered until deployment into tissue. For example, a spring loaded sheath or housing can be pushed distally along the long axis of the tip to expose the sharp tip. For example, as shown in FIGS. 10A and 10B, a stylet 900 can include a spring-loaded mechanism 902 on the distal end of a stylet body 910. Thus, a coiled member 904 can be configured to extend over the tip 906 of the stylet, which can be sharp and/or tapered. Referring to FIG. 10A, in the passive mode, i.e. before contacting tissue, the coiled member 904 can cover the tapered or sharp end of the stylet so that the end is atraumatic in non-targeted areas. Once the location of re-entry is reached, the tip 906 can be advanced into the tissue, thus activating the spring mechanism (shown in FIG. 10B) as the coil compresses and exposes the penetrating tip 906.


The length of exposed tip 906 can be controlled by placing the coiled member 904 in the desired location along the stylet body 910. Accordingly, the initial length of the tip 906 that is exposed through the vessel wall or occlusion can be limited by the coiled member 904, advantageously avoiding over-puncturing and possibly hitting the opposing vessel wall. Further, the pitch of the coiled member 904 can be chosen based upon the desired spring force required to penetrate or puncture the tissue, such as based upon the type or thickness of the tissue. Once the tip has been pushed fully through, the coiled member 904 can act as a temporary stop, providing tactile feedback for the user and allowing the user to adjust the angle or orientation of the stylet tip. Additional force can then be placed on the stylet 900 to push the coiled member 904 through. Once the proximal end of the coiled member 904 is fully advanced through the tissue, the coiled member can relax, allowing the stylet 900 to be in passive mode again as it traverses through the vessel.


Although a coiled member 904 is shown in FIGS. 10A and 10B, other spring loaded mechanisms 902 are possible. Advantageously, spring loaded mechanisms 902 on the stylet can help control depth of penetration and also provide a safer method of controlling re-entry. The spring-loaded mechanism 902 can be used with a traditional stylet or with any of the stylets described herein.


Referring to FIG. 8, a handle 800 can be used to steer any of the stylets described herein. The handle 800 can include a locking mechanism to lock it onto the proximal end of the device, such as a luer fitting. In one embodiment, the handle 800 can have predefined positions that align the stylet appropriately with the catheter. For example, if the handle 800 is used with the stylet 200, the handle can lock the stylet 200 in a first position where the stylet 300 is proximal of the bend in the catheter, thereby allowing the main body of the catheter to have extra support. The handle can also lock the stylet 200 in a second position where the distal stiff section of the stylet 200 is in the prebent section of the catheter, thereby straightening the catheter. Finally, the handle 800 can lock the stylet 200 in a third position where the distal part of the stylet 200 sticks out of the distal tip of the catheter, thereby enabling re-entry into the true lumen. The handle 800 can include similar predefined positions when used with the other stylets described in here.


Any of the embodiments of stylets herein can include an anchoring mechanism on or near the distal tip. For example, the distal end can include a hook 991 as shown in FIG. 9A or a drill tip 993 as shown in FIG. 9B. The anchoring mechanism can anchor the stylet in a particular location where re-entry is desired, i.e., can prevent proximal movement, and then can be dislodged as the stylet is advanced distally past the location.


Any of the stylets described herein can include a marker, such as a radiopaque marker, to help identify the location of the stylet in situ with imaging. For example, referring to the stylet 100 of FIGS. 1A-2C, the connector 106 between the proximal portion 101 and the middle portion 102 can form the radiopaque marker. In some embodiments, a radiopaque coating, such as platinum, can be applied to portions of the stylet 100.


Any of the stylets described herein can include a torquer configured to be tightened onto the stylet for rotational control. In some embodiments, the torquer can be aligned with a particular angle in the stylet. For example, the torquer can align with one or more of the angles of the s-curve 107 of the stylet 100.


Any of the stylets described herein can be sized and configured to fit within a guidewire channel of a catheter, such as through a guidewire channel of an occlusion-crossing device. Such exemplary occlusion-crossing devices are described in co-pending patent applications: U.S. patent application Ser. No. 12/829,267, titled “CATHETER-BASED OFF-AXIS OPTICAL COHERENCE TOMOGRAPHY IMAGING SYSTEM,” filed Jul. 1, 2010, Publication No. US-2010-0021926-A1; U.S. patent application Ser. No. 13/433,049, titled “OCCLUSION-CROSSING DEVICES, IMAGING, AND ATHERECTOMY DEVICES,” filed Mar. 28, 2012, Publication No. US-2012-0253186-A1; International Patent Application titled “OCCLUSION-CROSSING DEVICES,” filed herewith; and International Patent Application titled “CHRONIC TOTAL OCCLUSION CROSSING DEVICES WITH IMAGING,” filed herewith, all of which are incorporated by reference in their entireties.


Further, any of the stylets and/or catheters described herein can be oriented, directed, or steered using image guidance, such as optical coherence tomography, ultrasound, radiofrequency imaging, or fluoroscopy.


Additional details pertinent to the present invention, including materials and manufacturing techniques, may be employed as within the level of those with skill in the relevant art. The same may hold true with respect to method-based aspects of the invention in terms of additional acts commonly or logically employed. Also, it is contemplated that any optional feature of the inventive variations described may be set forth and claimed independently, or in combination with any one or more of the features described herein. Likewise, reference to a singular item, includes the possibility that there are a plurality of the same items present. More specifically, as used herein and in the appended claims, the singular forms “a,” “and,” “said,” and “the” include plural referents unless the context clearly dictates otherwise. It is further noted that the claims may be drafted to exclude any optional element. As such, this statement is intended to serve as antecedent basis for use of such exclusive terminology as “solely,” “only” and the like in connection with the recitation of claim elements, or use of a “negative” limitation. Unless defined otherwise herein, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The breadth of the present invention is not to be limited by the subject specification, but rather only by the plain meaning of the claim terms employed.


When a feature or element is herein referred to as being “on” another feature or element, it can be directly on the other feature or element or intervening features and/or elements may also be present. In contrast, when a feature or element is referred to as being “directly on” another feature or element, there are no intervening features or elements present. It will also be understood that, when a feature or element is referred to as being “connected”, “attached” or “coupled” to another feature or element, it can be directly connected, attached or coupled to the other feature or element or intervening features or elements may be present. In contrast, when a feature or element is referred to as being “directly connected”, “directly attached” or “directly coupled” to another feature or element, there are no intervening features or elements present. Although described or shown with respect to one embodiment, the features and elements so described or shown can apply to other embodiments. It will also be appreciated by those of skill in the art that references to a structure or feature that is disposed “adjacent” another feature may have portions that overlap or underlie the adjacent feature.


Terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. For example, as used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises” and/or “comprising,” when used in this specification, specify the presence of stated features, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, steps, operations, elements, components, and/or groups thereof. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items and may be abbreviated as “/”.


Spatially relative terms, such as “under”, “below”, “lower”, “over”, “upper” and the like, may be used herein for ease of description to describe one element or feature's relationship to another element(s) or feature(s) as illustrated in the figures. It will be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the figures. For example, if a device in the figures is inverted, elements described as “under” or “beneath” other elements or features would then be oriented “over” the other elements or features. Thus, the exemplary term “under” can encompass both an orientation of over and under. The device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein interpreted accordingly. Similarly, the terms “upwardly”, “downwardly”, “vertical”, “horizontal” and the like are used herein for the purpose of explanation only unless specifically indicated otherwise.


Although the terms “first” and “second” may be used herein to describe various features/elements, these features/elements should not be limited by these terms, unless the context indicates otherwise. These terms may be used to distinguish one feature/element from another feature/element. Thus, a first feature/element discussed below could be termed a second feature/element, and similarly, a second feature/element discussed below could be termed a first feature/element without departing from the teachings of the present invention.


As used herein in the specification and claims, including as used in the examples and unless otherwise expressly specified, all numbers may be read as if prefaced by the word “about” or “approximately,” even if the term does not expressly appear. The phrase “about” or “approximately” may be used when describing magnitude and/or position to indicate that the value and/or position described is within a reasonable expected range of values and/or positions. For example, a numeric value may have a value that is +/−0.1% of the stated value (or range of values), +/−1% of the stated value (or range of values), +/−2% of the stated value (or range of values), +/−5% of the stated value (or range of values), +/−10% of the stated value (or range of values), etc. Any numerical range recited herein is intended to include all sub-ranges subsumed therein.

Claims
  • 1. A stylet for re-entry into a vessel comprising: an elongate body having a proximal portion, a middle curved portion, a pointed distal end, and a longitudinal axis extending through the proximal portion, the middle curved portion, and the pointed distal end;wherein the proximal portion and the middle curved portion have substantially circular cross-sections, and wherein the middle curved portion has a pre-shaped curve along the longitudinal axis configured to match a curve of an occlusion-crossing device;wherein the pointed distal end has an s-shaped curve along the longitudinal axis and a flattened portion along the longitudinal axis, the flattened portion having a substantially oblong cross-section; and wherein the flattened portion tapers to a sharp tip at the pointed distal end.
  • 2. The stylet of claim 1, wherein the s-shaped curve is within the flattened portion.
  • 3. The stylet of claim 1, wherein at least one of the distal end or the middle curved portion comprises nitinol.
  • 4. The stylet of claim 1, wherein the proximal portion comprises stainless steel.
  • 5. The stylet of claim 1, wherein the pre-shaped curve forms an angle of 130 to 170 degrees.
  • 6. The stylet of claim 5, wherein the angle is approximately 150 degrees.
  • 7. The stylet of claim 1, wherein the s-shaped curve has two curves, the first curve forming a first angle of 120 to 160 degrees and the second curve forming an angle of 120 to 160 degrees.
  • 8. The stylet of claim 1, wherein the s-shaped curve has a first curve and a second curve, the second curve distal to the first curve, and wherein the pre-shaped curve is aligned in substantially the same direction as the second curve.
  • 9. The stylet of claim 1, wherein the pointed distal end includes an anchor.
  • 10. The stylet of claim 1, wherein the pointed distal end is configured to penetrate a vessel wall.
  • 11. The stylet of claim 1, wherein the pointed distal end has the s-shaped curve when deployed from the occlusion-crossing device.
  • 12. A method of re-entering a true lumen during occlusion-crossing comprising: orienting a distal end of a catheter having a bend therein towards the true lumen of a vessel;introducing a stylet through a guidewire channel of the catheter, the stylet comprising: an elongate body having a proximal portion, a middle curved portion, a pointed distal end, and a longitudinal axis extending through the proximal portion, the middle curved portion, and the pointed distal end,wherein the proximal portion and the middle curved portion have substantially circular cross-sections, and wherein the middle curved portion has a pre-shaped curve along the longitudinal axis configured to match a curve of an occlusion-crossing device,wherein the pointed distal end has an s-shaped curve along the longitudinal axis and a flattened portion along the longitudinal axis, the flattened portion having a substantially oblong cross-section,wherein the flattened portion tapers to a sharp tip at the pointed distal end, andwherein inserting the stylet comprises inserting until the curved middle portion of the stylet aligns with the bend in the catheter and the pointed distal end of the stylet extends out of a distal end of the catheter; andadvancing the stylet such that the pointed distal end pierces through a wall of the vessel; anddirecting the catheter over the stylet and into the true lumen of the vessel.
  • 13. The method of claim 12, further comprising orienting the stylet within the catheter such that the pointed distal end of the stylet curves towards the vessel wall before advancing the stylet.
  • 14. The method of claim 12, further comprising reorienting the catheter within the true lumen after directing the catheter over the stylet.
  • 15. The method of claim 12, wherein reorienting the catheter comprises reorienting without puncturing an opposite vessel wall.
  • 16. The method of claim 12, further comprising determining an orientation of the stylet based upon an alignment of the curved middle portion with the bend in the catheter.
  • 17. The method of claim 12, further comprising using image guidance to orient the catheter.
CROSS REFERENCE TO RELATED APPLICATION

This application claims the benefit of U.S. Provisional Patent Application No. 61/697,726, filed Sep. 6, 2012, and titled “RE-ENTRY STYLET FOR CATHETER,” which is herein incorporated by reference in its entirety. All publications and patent applications mentioned in this specification are herein incorporated by reference in their entireties to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.

PCT Information
Filing Document Filing Date Country Kind
PCT/US2013/032196 3/15/2013 WO 00
Publishing Document Publishing Date Country Kind
WO2015/039096 3/13/2014 WO A
US Referenced Citations (439)
Number Name Date Kind
3908637 Doroshow Sep 1975 A
4178935 Gekhaman et al. Dec 1979 A
4487206 Aagard Dec 1984 A
4527553 Upsher Jul 1985 A
4552554 Gould et al. Nov 1985 A
4621353 Hazel et al. Nov 1986 A
4639091 Huignard et al. Jan 1987 A
4654024 Crittenden et al. Mar 1987 A
4686982 Nash Aug 1987 A
4691708 Kane Sep 1987 A
4771774 Simpson et al. Sep 1988 A
4841977 Griffith et al. Jun 1989 A
4857046 Stevens et al. Aug 1989 A
4920961 Grossi et al. May 1990 A
4926858 Gifford, III et al. May 1990 A
5000185 Yock Mar 1991 A
5018529 Tenerz et al. May 1991 A
5041082 Shiber Aug 1991 A
5047040 Simpson et al. Sep 1991 A
5085662 Willard Feb 1992 A
5099850 Matsui et al. Mar 1992 A
5178153 Einzig Jan 1993 A
5182291 Gubin et al. Jan 1993 A
5190050 Nitzsche Mar 1993 A
5192291 Pannek, Jr. Mar 1993 A
5312415 Palermo May 1994 A
5312425 Evans et al. May 1994 A
5321501 Swanson et al. Jun 1994 A
5333142 Scheps Jul 1994 A
5358472 Vance et al. Oct 1994 A
5366464 Belknap Nov 1994 A
5383460 Jang et al. Jan 1995 A
5383467 Auer et al. Jan 1995 A
5425273 Chevalier Jun 1995 A
5429136 Milo et al. Jul 1995 A
5431673 Summers et al. Jul 1995 A
5437284 Trimble Aug 1995 A
5459570 Swanson et al. Oct 1995 A
5460168 Masubuchi et al. Oct 1995 A
5465147 Swanson Nov 1995 A
5507795 Chiang et al. Apr 1996 A
5556405 Lary Sep 1996 A
5607394 Andersen Mar 1997 A
5620426 Braithwaite Apr 1997 A
5632754 Farley et al. May 1997 A
5632755 Nordgren et al. May 1997 A
5674232 Halliburton Oct 1997 A
5681336 Clement et al. Oct 1997 A
5690634 Muller et al. Nov 1997 A
5722403 McGee et al. Mar 1998 A
5728148 Bostrom Mar 1998 A
5795295 Hellmuth et al. Aug 1998 A
5807339 Bostrom et al. Sep 1998 A
5830145 Tenhoff Nov 1998 A
5836957 Schulz et al. Nov 1998 A
5843050 Jones et al. Dec 1998 A
5843103 Wulfman Dec 1998 A
5868778 Gershony et al. Feb 1999 A
5872879 Hamm Feb 1999 A
5904651 Swanson et al. May 1999 A
5907425 Dickensheets et al. May 1999 A
5935075 Casscells et al. Aug 1999 A
5938602 Lloyd Aug 1999 A
5951482 Winston et al. Sep 1999 A
5951581 Saadat et al. Sep 1999 A
5951583 Jensen et al. Sep 1999 A
5956355 Swanson et al. Sep 1999 A
5957952 Gershony et al. Sep 1999 A
5987995 Sawatari et al. Nov 1999 A
5997558 Nash Dec 1999 A
6001112 Taylor Dec 1999 A
6007530 Dornhofer et al. Dec 1999 A
6010449 Selmon et al. Jan 2000 A
6013072 Winston et al. Jan 2000 A
6017359 Gershony et al. Jan 2000 A
6027514 Stine et al. Feb 2000 A
6032673 Savage et al. Mar 2000 A
6048349 Winston et al. Apr 2000 A
6080170 Nash et al. Jun 2000 A
6106515 Winston et al. Aug 2000 A
6110164 Vidlund Aug 2000 A
6120515 Rogers et al. Sep 2000 A
6120516 Selmon et al. Sep 2000 A
6134002 Stimson et al. Oct 2000 A
6134003 Tearney et al. Oct 2000 A
6152938 Curry Nov 2000 A
6152951 Hashimoto et al. Nov 2000 A
6160826 Swanson et al. Dec 2000 A
6175669 Colston et al. Jan 2001 B1
6176871 Pathak et al. Jan 2001 B1
6183432 Milo Feb 2001 B1
6193676 Winston et al. Feb 2001 B1
6206898 Honeycutt et al. Mar 2001 B1
6228076 Winston et al. May 2001 B1
6241744 Imran et al. Jun 2001 B1
6283957 Hashimoto et al. Sep 2001 B1
6290668 Gregory et al. Sep 2001 B1
6294775 Seibel et al. Sep 2001 B1
6299622 Snow et al. Oct 2001 B1
6307985 Murakami et al. Oct 2001 B1
6402719 Ponzi et al. Jun 2002 B1
6416527 Berg et al. Jul 2002 B1
6445939 Swanson et al. Sep 2002 B1
6445944 Ostrovsky Sep 2002 B1
6447525 Follmer et al. Sep 2002 B2
6451036 Heitzmann et al. Sep 2002 B1
6454717 Pantages et al. Sep 2002 B1
6454779 Taylor Sep 2002 B1
6482216 Hiblar et al. Nov 2002 B1
6482217 Pintor et al. Nov 2002 B1
6485413 Boppart et al. Nov 2002 B1
6497649 Parker et al. Dec 2002 B2
6501551 Tearney et al. Dec 2002 B1
6503261 Bruneau et al. Jan 2003 B1
6511458 Milo et al. Jan 2003 B2
6517528 Pantages et al. Feb 2003 B1
6542665 Reed et al. Apr 2003 B2
6546272 MacKinnon et al. Apr 2003 B1
6551302 Rosinko et al. Apr 2003 B1
6563105 Seibel et al. May 2003 B2
6564087 Pitris et al. May 2003 B1
6565588 Clement et al. May 2003 B1
6572563 Ouchi et al. Jun 2003 B2
6572643 Gharibadeh Jun 2003 B1
6575995 Huter et al. Jun 2003 B1
6579298 Bruneau et al. Jun 2003 B1
6615071 Casscells, III et al. Sep 2003 B1
6638233 Corvi et al. Oct 2003 B2
6645217 MacKinnon et al. Nov 2003 B1
6657727 Izatt et al. Dec 2003 B1
6666874 Heitzmann et al. Dec 2003 B2
6687010 Horii Feb 2004 B1
6728571 Barbet Apr 2004 B1
D489973 Root et al. May 2004 S
6730063 Delaney et al. May 2004 B2
6758854 Butler et al. Jul 2004 B1
6760112 Reed et al. Jul 2004 B2
6800085 Selmon et al. Oct 2004 B2
6818001 Wulfman et al. Nov 2004 B2
6824550 Noriega et al. Nov 2004 B1
6830577 Nash et al. Dec 2004 B2
6845190 Smithwick et al. Jan 2005 B1
6852109 Winston et al. Feb 2005 B2
6853457 Bjarklev et al. Feb 2005 B2
6856712 Fauver et al. Feb 2005 B2
6867753 Chinthammit et al. Mar 2005 B2
6879851 McNamara et al. Apr 2005 B2
6947787 Webler Sep 2005 B2
6961123 Wang et al. Nov 2005 B1
6970732 Winston et al. Nov 2005 B2
6975898 Seibel Dec 2005 B2
7068878 Crossman-Bosworth et al. Jun 2006 B2
7074231 Jang Jul 2006 B2
7126693 Everett et al. Oct 2006 B2
7172610 Heitzmann et al. Feb 2007 B2
7242480 Alphonse Jul 2007 B2
7261687 Yang Aug 2007 B2
7288087 Winston et al. Oct 2007 B2
7291146 Steinke et al. Nov 2007 B2
7297131 Nita Nov 2007 B2
7311723 Seibel et al. Dec 2007 B2
7344546 Wulfman et al. Mar 2008 B2
7366376 Shishkov et al. Apr 2008 B2
7382949 Bouma et al. Jun 2008 B2
7426036 Feldchtein et al. Sep 2008 B2
7428001 Schowengerdt et al. Sep 2008 B2
7428053 Feldchtein et al. Sep 2008 B2
7455649 Root et al. Nov 2008 B2
7474407 Gutin Jan 2009 B2
7485127 Nistal Feb 2009 B2
7488340 Kauphusman et al. Feb 2009 B2
7530948 Seibel et al. May 2009 B2
7530976 MacMahon et al. May 2009 B2
7538859 Tearney et al. May 2009 B2
7538886 Feldchtein May 2009 B2
7539362 Teramura May 2009 B2
7542145 Toida et al. Jun 2009 B2
7544162 Ohkubo Jun 2009 B2
7545504 Buckland et al. Jun 2009 B2
7555333 Wang et al. Jun 2009 B2
7577471 Camus et al. Aug 2009 B2
7583872 Seibel et al. Sep 2009 B2
7616986 Seibel et al. Nov 2009 B2
7637885 Maschke Dec 2009 B2
7674253 Fisher et al. Mar 2010 B2
7682319 Martin et al. Mar 2010 B2
7706863 Imanishi et al. Apr 2010 B2
7728985 Feldchtein et al. Jun 2010 B2
7729745 Maschke Jun 2010 B2
7734332 Sher Jun 2010 B2
7738945 Fauver et al. Jun 2010 B2
7753852 Maschke Jul 2010 B2
7771425 Dycus et al. Aug 2010 B2
7785286 Magnin et al. Aug 2010 B2
7813609 Petersen et al. Oct 2010 B2
7821643 Amazeen et al. Oct 2010 B2
7824089 Charles Nov 2010 B2
7840283 Bush et al. Nov 2010 B1
7944568 Teramura et al. May 2011 B2
7952718 Li et al. May 2011 B2
7972299 Carter et al. Jul 2011 B2
8059274 Splinter Nov 2011 B2
8062316 Patel et al. Nov 2011 B2
8068921 Prakash Nov 2011 B2
8313493 Fisher Nov 2012 B2
8361097 Patel et al. Jan 2013 B2
8548571 He et al. Oct 2013 B2
8548603 Swoyer et al. Oct 2013 B2
8632557 Thatcher et al. Jan 2014 B2
8644913 Simpson et al. Feb 2014 B2
8696695 Patel et al. Apr 2014 B2
8911459 Simpson et al. Dec 2014 B2
9119662 Moberg Sep 2015 B2
9351757 Kusleika May 2016 B2
20010020126 Swanson et al. Sep 2001 A1
20020019644 Hastings et al. Feb 2002 A1
20020072706 Hiblar et al. Jun 2002 A1
20020082626 Donohoe et al. Jun 2002 A1
20020111548 Swanson et al. Aug 2002 A1
20020115931 Strauss et al. Aug 2002 A1
20020147459 Bashiri et al. Oct 2002 A1
20020158547 Wood Oct 2002 A1
20030002038 Mawatari Jan 2003 A1
20030028100 Tearney et al. Feb 2003 A1
20030032880 Moore Feb 2003 A1
20030045835 Anderson et al. Mar 2003 A1
20030095248 Frot May 2003 A1
20030097044 Rovegno May 2003 A1
20030120150 Govari Jun 2003 A1
20030120295 Simpson et al. Jun 2003 A1
20030125756 Shturman et al. Jul 2003 A1
20030125757 Patel et al. Jul 2003 A1
20030125758 Simpson et al. Jul 2003 A1
20030181855 Simpson et al. Sep 2003 A1
20040002650 Mandrusov et al. Jan 2004 A1
20040039371 Tockman et al. Feb 2004 A1
20040057667 Yamada et al. Mar 2004 A1
20040059257 Gaber Mar 2004 A1
20040082850 Bonner et al. Apr 2004 A1
20040092915 Levatter May 2004 A1
20040093001 Hamada May 2004 A1
20040147934 Kiester Jul 2004 A1
20040167553 Simpson et al. Aug 2004 A1
20040167554 Simpson et al. Aug 2004 A1
20040181249 Torrance et al. Sep 2004 A1
20040186368 Ramzipoor et al. Sep 2004 A1
20040202418 Ghiron et al. Oct 2004 A1
20040220519 Wulfman et al. Nov 2004 A1
20040230212 Wulfman Nov 2004 A1
20040230213 Wulfman et al. Nov 2004 A1
20040236312 Nistal et al. Nov 2004 A1
20040243162 Wulfman et al. Dec 2004 A1
20040254599 Lipoma et al. Dec 2004 A1
20040260236 Manning et al. Dec 2004 A1
20050020925 Kleen et al. Jan 2005 A1
20050043614 Huizenga et al. Feb 2005 A1
20050054947 Goldenberg Mar 2005 A1
20050075660 Chu Apr 2005 A1
20050085708 Fauver et al. Apr 2005 A1
20050085721 Fauver et al. Apr 2005 A1
20050105097 Fang-Yen et al. May 2005 A1
20050141843 Warden et al. Jun 2005 A1
20050154407 Simpson Jul 2005 A1
20050159712 Andersen Jul 2005 A1
20050159731 Lee Jul 2005 A1
20050171478 Selmon et al. Aug 2005 A1
20050177068 Simpson Aug 2005 A1
20050182295 Soper et al. Aug 2005 A1
20050187571 Maschke Aug 2005 A1
20050192496 Maschke Sep 2005 A1
20050201662 Petersen et al. Sep 2005 A1
20050203553 Maschke Sep 2005 A1
20050222519 Simpson Oct 2005 A1
20050222663 Simpson et al. Oct 2005 A1
20050251116 Steinke et al. Nov 2005 A1
20060032508 Simpson Feb 2006 A1
20060046235 Alexander Mar 2006 A1
20060049587 Cornwell Mar 2006 A1
20060064009 Webler et al. Mar 2006 A1
20060084911 Belef et al. Apr 2006 A1
20060109478 Tearney et al. May 2006 A1
20060135870 Webler Jun 2006 A1
20060173475 Lafontaine et al. Aug 2006 A1
20060229646 Sparks Oct 2006 A1
20060229659 Gifford et al. Oct 2006 A1
20060235262 Arnal Oct 2006 A1
20060235366 Simpson Oct 2006 A1
20060236019 Soito et al. Oct 2006 A1
20060239982 Simpson Oct 2006 A1
20060241503 Schmitt et al. Oct 2006 A1
20060244973 Yun et al. Nov 2006 A1
20060252993 Freed et al. Nov 2006 A1
20060264741 Prince Nov 2006 A1
20060264743 Kleen et al. Nov 2006 A1
20060264907 Eskridge et al. Nov 2006 A1
20070010840 Rosenthal et al. Jan 2007 A1
20070015969 Feldman et al. Jan 2007 A1
20070015979 Redel Jan 2007 A1
20070035855 Dickensheets Feb 2007 A1
20070038061 Huennekens et al. Feb 2007 A1
20070038125 Kleen et al. Feb 2007 A1
20070038173 Simpson Feb 2007 A1
20070078469 Soito et al. Apr 2007 A1
20070081166 Brown et al. Apr 2007 A1
20070088230 Terashi et al. Apr 2007 A1
20070106155 Goodnow et al. May 2007 A1
20070135712 Maschke Jun 2007 A1
20070196926 Soito et al. Aug 2007 A1
20070219484 Straub Sep 2007 A1
20070250080 Jones et al. Oct 2007 A1
20070255252 Mehta Nov 2007 A1
20070270647 Nahen et al. Nov 2007 A1
20070276419 Rosenthal Nov 2007 A1
20070288036 Seshadri Dec 2007 A1
20070299309 Seibel et al. Dec 2007 A1
20080004643 To et al. Jan 2008 A1
20080004644 To et al. Jan 2008 A1
20080004645 To et al. Jan 2008 A1
20080004646 To et al. Jan 2008 A1
20080015491 Bei et al. Jan 2008 A1
20080027334 Langston Jan 2008 A1
20080033396 Danek et al. Feb 2008 A1
20080045986 To et al. Feb 2008 A1
20080049234 Seitz Feb 2008 A1
20080058629 Seibel et al. Mar 2008 A1
20080065124 Olson Mar 2008 A1
20080065125 Olson Mar 2008 A1
20080065205 Nguyen et al. Mar 2008 A1
20080103439 Torrance et al. May 2008 A1
20080103446 Torrance et al. May 2008 A1
20080103516 Wulfman et al. May 2008 A1
20080139897 Ainsworth et al. Jun 2008 A1
20080146942 Dala-Krishna Jun 2008 A1
20080147000 Seibel et al. Jun 2008 A1
20080154293 Taylor et al. Jun 2008 A1
20080177138 Courtney et al. Jul 2008 A1
20080186501 Xie Aug 2008 A1
20080221388 Seibel et al. Sep 2008 A1
20080228033 Tumlinson et al. Sep 2008 A1
20080243030 Seibel et al. Oct 2008 A1
20080243031 Seibel et al. Oct 2008 A1
20080262312 Carroll et al. Oct 2008 A1
20080275485 Bonnette et al. Nov 2008 A1
20090018565 To et al. Jan 2009 A1
20090018566 Escudero et al. Jan 2009 A1
20090018567 Escudero et al. Jan 2009 A1
20090024084 Khosla et al. Jan 2009 A1
20090024085 To et al. Jan 2009 A1
20090024191 Seibel et al. Jan 2009 A1
20090028407 Seibel et al. Jan 2009 A1
20090028507 Jones et al. Jan 2009 A1
20090073444 Wang Mar 2009 A1
20090093764 Pfeffer et al. Apr 2009 A1
20090099641 Wu et al. Apr 2009 A1
20090125019 Douglass et al. May 2009 A1
20090135280 Johnston et al. May 2009 A1
20090137893 Seibel et al. May 2009 A1
20090152664 Tian et al. Jun 2009 A1
20090185135 Volk Jul 2009 A1
20090196554 Irisawa Aug 2009 A1
20090198125 Nakabayashi et al. Aug 2009 A1
20090208143 Yoon et al. Aug 2009 A1
20090216180 Lee et al. Aug 2009 A1
20090221904 Shealy et al. Sep 2009 A1
20090221920 Boppart et al. Sep 2009 A1
20090235396 Wang et al. Sep 2009 A1
20090244485 Walsh et al. Oct 2009 A1
20090244547 Ozawa Oct 2009 A1
20090264826 Thompson Oct 2009 A1
20090284749 Johnson et al. Nov 2009 A1
20090292199 Bielewicz et al. Nov 2009 A1
20090306520 Schmitt et al. Dec 2009 A1
20090316116 Melville et al. Dec 2009 A1
20090318862 Ali et al. Dec 2009 A1
20100049225 To et al. Feb 2010 A1
20100080016 Fukui et al. Apr 2010 A1
20100125253 Olson May 2010 A1
20100130996 Doud et al. May 2010 A1
20100241147 Maschke Sep 2010 A1
20100253949 Adler et al. Oct 2010 A1
20100292539 Lankenau et al. Nov 2010 A1
20100292721 Moberg Nov 2010 A1
20100305452 Black et al. Dec 2010 A1
20100312263 Moberg et al. Dec 2010 A1
20100317973 Nita Dec 2010 A1
20100324472 Wulfman Dec 2010 A1
20110004107 Rosenthal et al. Jan 2011 A1
20110021926 Spencer et al. Jan 2011 A1
20110023617 Miao et al. Feb 2011 A1
20110028977 Rauscher et al. Feb 2011 A1
20110040238 Wulfman et al. Feb 2011 A1
20110058250 Liu et al. Mar 2011 A1
20110060186 Tilson et al. Mar 2011 A1
20110071401 Hastings et al. Mar 2011 A1
20110092955 Purdy et al. Apr 2011 A1
20110106004 Eubanks et al. May 2011 A1
20110118660 Torrance et al. May 2011 A1
20110130777 Zhang et al. Jun 2011 A1
20110144673 Zhang et al. Jun 2011 A1
20110201924 Tearney et al. Aug 2011 A1
20110257478 Kleiner et al. Oct 2011 A1
20110264125 Wilson et al. Oct 2011 A1
20110270187 Nelson Nov 2011 A1
20110295148 Destoumieux et al. Dec 2011 A1
20110301625 Mauch et al. Dec 2011 A1
20110319905 Palme et al. Dec 2011 A1
20120002928 Irisawa Jan 2012 A1
20120004506 Tearney et al. Jan 2012 A1
20120046679 Patel et al. Feb 2012 A1
20120123352 Fruland et al. May 2012 A1
20120238869 Schmitt et al. Sep 2012 A1
20120259337 del Rio et al. Oct 2012 A1
20120289971 Segermark et al. Nov 2012 A1
20130035692 Sorensen et al. Feb 2013 A1
20130096589 Spencer et al. Apr 2013 A1
20130123615 Spencer et al. May 2013 A1
20130138128 Patel et al. May 2013 A1
20130211221 Sunnarborg et al. Aug 2013 A1
20130223798 Jenner et al. Aug 2013 A1
20130223801 Bhagavatula et al. Aug 2013 A1
20130255069 Higashi et al. Oct 2013 A1
20130266259 Bhagavatula et al. Oct 2013 A1
20130289392 Patel et al. Oct 2013 A1
20130296695 Spencer et al. Nov 2013 A1
20130317519 Romo et al. Nov 2013 A1
20140005534 He et al. Jan 2014 A1
20140128893 Guggenheimer et al. May 2014 A1
20140187949 Zhao et al. Jul 2014 A1
20140213893 Simpson et al. Jul 2014 A1
20140222047 Vreeman Aug 2014 A1
20140371718 Alvarez et al. Dec 2014 A1
20150025310 Everingham et al. Jan 2015 A1
20150099984 Kankaria Apr 2015 A1
20150126856 Tachibana et al. May 2015 A1
20150164530 Carver et al. Jun 2015 A1
20150208922 Newhauser et al. Jul 2015 A1
20160192962 Simpson et al. Jul 2016 A1
20160199092 Patel et al. Jul 2016 A1
20180256187 Patel et al. Sep 2018 A1
Foreign Referenced Citations (76)
Number Date Country
1875242 Dec 2006 CN
1947652 Apr 2007 CN
101601581 Dec 2009 CN
103027727 Apr 2013 CN
202006018883.5 Feb 2007 DE
0347098 Dec 1989 EP
0808638 Nov 1997 EP
1859732 Nov 2007 EP
2353526 Sep 2013 EP
S62-275425 Nov 1987 JP
03502060 Feb 1990 JP
05103763 Apr 1993 JP
H06-027343 Feb 1994 JP
H07-308393 Nov 1995 JP
2002-214127 Jul 2002 JP
2004-509695 Apr 2004 JP
2004-516073 Jun 2004 JP
2005-114473 Apr 2005 JP
2005-249704 Sep 2005 JP
2005-533533 Nov 2005 JP
2008-175698 Jul 2006 JP
2006-288775 Oct 2006 JP
2006-313158 Nov 2006 JP
2006-526790 Nov 2006 JP
2006-326157 Dec 2006 JP
2007-83053 Apr 2007 JP
2007-83057 Apr 2007 JP
2007-225349 Sep 2007 JP
2007533361 Nov 2007 JP
2008-023627 Feb 2008 JP
2008-128708 Jun 2008 JP
2008-145376 Jun 2008 JP
2008-183208 Aug 2008 JP
2008-253492 Oct 2008 JP
2009-14751 Jan 2009 JP
2009-509690 Mar 2009 JP
2009-66252 Apr 2009 JP
2009-78150 Apr 2009 JP
2010042182 Feb 2010 JP
2010518900 Jun 2010 JP
2011521747 Jul 2011 JP
2012533353 Dec 2012 JP
2016508758 Mar 2016 JP
20070047221 May 2007 KR
2185859 Jul 2002 RU
2218191 Dec 2003 RU
WO 9117698 Nov 1991 WO
WO 9923958 May 1999 WO
WO 0054659 Sep 2000 WO
WO0115609 Mar 2001 WO
WO 0176680 Oct 2001 WO
WO 2006133030 Dec 2006 WO
WO2008005888 Jan 2008 WO
WO 2008029506 Mar 2008 WO
WO 2008042987 Apr 2008 WO
WO2008051951 May 2008 WO
WO 2008065600 Jun 2008 WO
WO 2008086613 Jul 2008 WO
WO 2008087613 Jul 2008 WO
WO2009005779 Jan 2009 WO
WO2009006335 Jan 2009 WO
WO 2009009799 Jan 2009 WO
WO2009009802 Jan 2009 WO
WO 2009023635 Feb 2009 WO
WO2009024344 Feb 2009 WO
WO 2009094341 Jul 2009 WO
WO 2009140617 Nov 2009 WO
WO2009148317 Dec 2009 WO
WO2010039464 Apr 2010 WO
WO2010056771 May 2010 WO
WO2011044387 Apr 2011 WO
WO2011062087 May 2011 WO
WO 2012061935 May 2012 WO
WO2012166332 Dec 2012 WO
WO2013033490 Mar 2013 WO
WO2013056262 Apr 2013 WO
Non-Patent Literature Citations (36)
Entry
Gupta et al.; U.S. Appl. No. 14/776,749 entitled “Tissue collection device for catheter,” filed Sep. 15, 2015.
Smith et al.; U.S. Appl. No. 14/776,750 entitled “Chronic total occlusion crossing devices with imaging,” filed Sep. 15, 2015.
Smith et al.; U.S. Appl. No. 14/776,748 entitled “Optical pressure sensor assembly,” filed Sep. 15, 2015.
Simpson et al.; U.S. Appl. No. 14/899,877 entitled “Occusion sheath for imaging catheter,” filed Dec. 18, 2015.
Simpson et al.; U.S. Appl. No. 14/899,893 entitled “Identification of elastic lamina to guide interventional therapy,” filed Dec. 18, 2015.
Patel et al.; U.S. Appl. No. 15/162,330 entitled “Atherectomy catheters with longitudinally displaceable drive shafts,” filed May 23, 2016.
Spencer et al.; U.S. Appl. No. 15/162,353 entitled “Occlusion-crossing devices, atherectomy devices, and imaging,” filed May 23, 2016.
Tachibana et al.; U.S. Appl. No. 15/162,391 entitled “Atherectomy catheter drive assemblies,” filed May 23, 2016.
Rosenthal et al.; U.S. Appl. No. 15/354,898 entitled “Atherectomy catheter with laterally-displaceable tip,” filed Nov. 17, 2017.
Patel et al.; U.S. Appl. No. 15/354,842 entitled “Atherectomy catheters and occlusion crossing devices,” filed Nov. 17, 2016.
Shinkle et al.; Evaluation of stent placement and outcomes with optical coherence tomography; Interv. Cardiol.; 2(4); pp. 535-543; (manuscript version, 12 pages); Aug. 2010.
Patel et al.; U.S. Appl. No. 15/324,325 entitled “High speed chronic total occulusion crossing devices,” filed Jan. 6, 2017.
Kankaria; U.S. Appl. No. 15/419,815 entitled “Optical coherence tomography with graded index fiber for biological imaging,” filed Jan. 30, 2017.
Simpson et al.; U.S. Appl. No. 15/434,758 entitled “Occlusion-crossing devices, imaging, and atherectomy devices,” filed Feb. 16, 2017.
Simpson et al.; U.S. Appl. No. 15/457,960 entitled “Atherectomy catheters devices having multi-channel bushings,” filed Mar. 13, 2017.
Patel et al.; U.S. Appl. No. 15/480,238 entitled “Guidewire positioning catheter,” filed Apr. 5, 2017.
Black et al.; U.S. Appl. No. 15/783,800 entitled “Optical coherence tomography for biological imaging,” filed Oct. 13, 2017.
Gupta et al.; U.S. Appl. No. 14/401,175 entitled “Atherectomy catheters with imaging,” filed Nov. 14, 2014.
Simpson et al.; U.S. Appl. No. 14/424,277 entitled “Balloon atherectomy catheters with imaging,” filed Feb. 26, 2015.
Aziz et al.; Chronic total occlusions—a stiff challege requiring a major breakthrough: is there light at the end of the tunnel?; Heart; vol. 91; suppl. III; pp. 42-48; Jun. 2005.
Emkey et al.; Analysis and evaluation of graded-index fiber-lenses; Journal of Lightwave Technology; vol. LT-5; No. 9; pp. 1156-1164; Sep. 1987.
Gonzalo et al.; Optical coherence tomography patterns of stent restenosis; Am. Heart J.; 158(2); pp. 284-293; Aug. 2009.
Linares et al.; Arbitrary single-mode coupling by tapered and nontapered grin fiber lenses; Applied Optics; vol. 29; No. 28; pp. 4003-4007; Oct. 1, 1990.
Sharma et al.; Optical coherence tomography based on an all-fiber autocorrelator using probe-end reflection as reference; CWJ13; San Francisco, California; CLEO May 16, 2004; 4 pages.
Suparno et al.; Light scattering with single-mode fiber collimators; Applied Optics; vol. 33; No. 30; pp. 7200-7205; Oct. 20, 1994.
Han et al.; In situ Frog Retina Imaging Using Common-Path OCT with a Gold-Coated Bare Fiber Probe; CFM6; San Jose, California; CLEO, May 4, 2008; 2 pages.
Muller et al.; Time-gated infrared fourier-domain optical coherence tomography; CFM5; San Jose, California; CLEO May 4, 2008; 2 pages.
Tanaka et al.; Challenges on the frontier of intracoronary imaging: atherosclerotic plaque macrophage measurement by optical coherence tomography; Journal of Biomedical Optics; 15(1); pp. (011104-1)-(011104-8); Jan.-Feb. 2010.
Wang et al.; Common-path endoscopic Fourier domain OCT with a reference Michelson interferometer; Proceedings of the SPIE; vol. 7566; pp. 75660L-75660L-7; Jan. 2010.
Smith et al.; U.S. Appl. No. 15/854,579 entitled “Chronic total occusion crossing devices with imaging,” filed Dec. 26, 2017.
Patel et al.; U.S. Appl. No. 15/741,928 entitled “Micro-molded anamorpjic reflector lens for image guided therapeutic/diagnostic catheters,” filed Jan. 4, 2018.
Zung et al.; U.S. Appl. No. 15/741,773 entitled “Self-alignment mechanism for imaging cather and drive assembly,” filed Jan. 4, 2018.
Newhauser et al.; U.S. Appl. No. 15/954,407 entitled “Occlusion-crossing devices,” filed Apr. 16, 2018.
Christensen; U.S. Appl. No. 16/069,545 entitled “OCT imaging catheter with lag correction,” filed Jul. 12, 2018.
Rosenthal et al.; U.S. Appl. No. 16/105,743 entitled “Atherectomy catheter with laterally-displaceable tip,” filed Aug. 20, 2018.
Patel et al.; U.S. Appl. No. 16/148,246 entitled “Atherectomy catheter with serrated cutter,” filed Oct. 1, 2018.
Related Publications (1)
Number Date Country
20150320975 A1 Nov 2015 US
Provisional Applications (1)
Number Date Country
61697726 Sep 2012 US